Inscription Capital’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-12,371
Closed -$563K – 256
2022
Q2
$563K Buy
+12,371
New +$581K 0.1% 139
2022
Q1
– Sell
-12,371
Closed -$641K – 227
2021
Q4
$641K Hold
12,371
– – 0.18% 114
2021
Q3
$597K Buy
+12,371
New +$615K 0.19% 108
2021
Q2
– Sell
-12,371
Closed -$550K – 398
2021
Q1
$550K Hold
12,371
– – 0.19% 105
2020
Q4
$535K Hold
12,371
– – 0.21% 98
2020
Q3
$494K Hold
12,371
– – 0.22% 90
2020
Q2
$465K Hold
12,371
– – 0.26% 75
2020
Q1
$403K Buy
+12,371
New +$442K 0.27% 76

Other funds holding JHMH

Inscription Capital's JHMH Position: Q3 2022 in Review

Inscription Capital sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q3 2022, closing a stake of 12,371 shares — an estimated $563K sold.

Inscription Capital first reported a position in JHMH in Q1 2020 and held it in 8 quarters. The position peaked at $641K in Q4 2021. 22 funds tracked by Wall St. Rank hold JHMH as of Q3 2022.

  • Inscription Capital reported no remaining John Hancock Multifactor Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • Inscription Capital sold 12,371 John Hancock Multifactor Healthcare ETF shares in Q3 2022, an estimated $563K.
  • Inscription Capital first reported a position in John Hancock Multifactor Healthcare ETF in Q1 2020 and held it in 8 quarters.
  • Inscription Capital's John Hancock Multifactor Healthcare ETF position peaked at $641K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q3 2022.

Based on Inscription Capital's 13F filing for Q3 2022, filed 14 Nov 2022.